Dr. Mario Gaudino recently appointed as the Director for the Joint Clinical Trials Office (JCTO) at Weill Cornell Medicine and New York Hospital. In his new role, Dr. Gaudino will oversee ongoing clinical trials and provide strategic growth plans to increase investigator-initiated trials, pragmatic trials, and ongoing improvements and enhancements to the existing clinical trial infrastructure.
Dr. Gaudino will collaborate closely with the Sandra and Edward Meyer Cancer Center and the other critical institutional entities for clinical research. He will help establish a vision for advancement, key metrics and targets, and provide oversight and leadership to the JCTO team. In this capacity, Dr. Gaudino will also serve as faculty liaison to Weill Cornell Medicine and NewYork-Presbyterian leadership, as well as clinical research faculty and departments. In collaboration with the Senior Associate Dean for Clinical Research, he will create a blueprint for expanding the clinical trials portfolio and associated revenue to support the growth targets across the full Weill Cornell and NewYork-Presbyterian network.